{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:26:06Z","timestamp":1786969566143,"version":"build-2736575974"},"reference-count":10,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2025,11,13]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Injectable long-acting cabotegravir plus rilpivirine (CAB+RPV\u2009LA) is an effective treatment option for people living with HIV. Unlike regimens containing tenofovir with lamivudine (3TC) or emtricitabine (FTC), it lacks therapeutic activity against the hepatitis B virus, and hepatitis B vaccination is recommended for non-immune individuals. We present a case of acute hepatitis B after switching to CAB+RPV\u2009LA in a previously vaccinated individual.<\/jats:p>","DOI":"10.1136\/sextrans-2025-056714","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:10:11Z","timestamp":1768558211000},"page":"51-53","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Acute hepatitis B following a switch to long-acting cabotegravir plus rilpivirine in an individual with a history of hepatitis B vaccination"],"prefix":"10.1136","volume":"102","author":[{"given":"Valentina","family":"Morena","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Alessandro Manzoni, Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Gemignani","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Alessandro Manzoni, Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bottanelli","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Alessandro Manzoni, Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Conti","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Alessandro Manzoni, Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Molteni","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Alessandro Manzoni, Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Valesecchi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Alessandro Manzoni, Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pontiggia","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Alessandro Manzoni, Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-1048","authenticated-orcid":false,"given":"Stefania","family":"Piconi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Alessandro Manzoni, Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"2026081704400938000_102.1.51.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904398"},{"key":"2026081704400938000_102.1.51.2","unstructured":"Hepatitis b and c epidemiology in selected population groups in the eu\/eea. European Center for Diseases Control and Prevention (ECDC); 2018."},{"key":"2026081704400938000_102.1.51.3","unstructured":"Hepatitis B . Annual epidemiological report for 2023. European Center for Diseases Control and Prevention (ECDC."},{"key":"2026081704400938000_102.1.51.4","unstructured":"EACS european aids clinical society guidelines. 2024."},{"key":"2026081704400938000_102.1.51.5","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1080\/21645515.2015.1055424","article-title":"Hepatitis B and A vaccination in HIV-infected adults: A review","volume":"11","author":"Mena","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"2026081704400938000_102.1.51.6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu867"},{"key":"2026081704400938000_102.1.51.7","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000384"},{"key":"2026081704400938000_102.1.51.8","unstructured":"Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vocabria-epar-product-information_en.pdf"},{"key":"2026081704400938000_102.1.51.9","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa367","article-title":"Acute Hepatitis B Infection After a Switch to Long-Acting Cabotegravir and Rilpivirine","volume":"7","author":"Pintado","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026081704400938000_102.1.51.10","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000001575","article-title":"Acute Hepatitis B Infection in a Patient With Confirmed Immunity on Long-Acting Cabotegravir\/Rilpivirine","volume":"12","author":"Boateng","year":"2025","journal-title":"ACG Case Rep J"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2025-056714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:40:21Z","timestamp":1786966821000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2025-056714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,16]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/sextrans-2025-056714"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2025-056714","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]}}}